United States             Oftio) of Posticidas and Toxic Substances
                    Environmental Protection      Office of Pesticide Programs (TS-766CI
                    Agency                 Washington, DC  20460

                    	540/FS-89-017
oEPA       Pesticide
                    Fact Sheet
                    Name of Chemical:  OXYTETRACYCLINE
                    Reason for Issuance:  REGISTRATION STANDARD
                    Date Issued: DECEMBER   1988
                    Facf Sheet Number:
 1.   DESCRIPTION OF CHEMICAL

     Generic Name:  Qxytetracycline
                   Qxytetracycline calcium complex
                   Qxytetracycline hydrochloride

     Chanical Name: 4-(dimethylamino)-l,4,4a,5,5a,6,ll,12a-octahydro-
                   3 , 5 , 6 , 10 , 12 , 12a-hexahydro-6-methyl-l , ll-dioxo-2-
                   naphthacenecarboxamide and its calcium conplex and
                   hydrochloride salts.

     Trade Names:   Glomycin, Terraf ungine , Riomitsin, Hydroxy-
     tetracycline,  Bertanycin,  Biostat, Impercin, Qxacycline, Qxyatets,
     Mycoshie.ld, Agricultural  Terramycin, Terramycin Hydrcxiiloride ,
     Terramycin.

     Chemical Class:  Antibiotic  (produced by the actinonycete
     Streptomyces rimosus)

     Pesticide Type: Plant Fungicide/Bactericide and Algicide

     CAS Registry Number:   79-57-2   (oxytetracycline)
                         7179-50-2   (calcium conplex)
                         2058-46-0   (hydrochloride)

     EPA Shaughnessy Codes: 006304  (oxytetracycline)
                           006321  -(calcium complex)
                           006308  (hydrochloride)
     Brpirical Formulae: C22^2^N2°S  (oxytetracycline)  Mol.  Wt. 460.44
                        C22H22N2°9 ^ (calcium complex) M.W.  498.52
                       -C22H24N2°9 .HCL (.hydrochloride)  M.W.  496. 9
     Year of Initial Registration:  August 1974

     U.S. and Foreiqn Producers:  Pfizer, Inc.

-------
 2.    USE FKT1TOMS »Nn FORMfflJOTICNS

          Type of Pesticide: Plant Fungicide/Bactericide and Algicide.

          Pests Controlled:  Bacterial and fungal diseases and slime-forming
          microorganisms.

          Registered Uses:

                1.  Calcium oxytetracycline [17% WP]:
                Nectarines, peaches, pears, and creeping
                Bentgrasses.

                2.  Oxytetracycline  hydrochloride  [21.6%
                Soluble Concentrate.
                -(Tree Trunk Injection) pears, peaches, and
                ornamental palms)
                - Marine  antifoulant paint additive.

                3.  Qxytetracycline  hydrochloride  [21.6%
                Soluble Concentrate.
                Formulation Intermediate for Marine
                antifoulant additive.

          Predominant Uses: Pears  and peaches (98%).

          Minor Uses:  Ornamental palms and Bentgrasses.

          Annual Usage:  21,350 pounds/ai

          Method of Application: Foliar, tree injection, and
          brush on (marine use).


3.   SCTEMCE FINDINGS

     Summary Science  Statement

     1.  Qxytetracycline hydrochloride  oncogenicity  data  indicates  equivocal
evidence  of oncogenicity in male and female rats.   The Agency  concludes  that,
although the findings were termed  "equivocal" by the National Toxicology Program,
they  do  not  represent  positive  evidence  of  carcinogenicity in  the  rat.   A
similar study in mice  indicated no evidence of oncogenicity.

     2.  Tolerances for  oxytetracycline  are limited  to peaches  (which  includes
nectarines) and pears, 0.1 ppm and 0.35 ppm respectively.   A Reference Dose (RfD)
of  l.O mgAg/day  has been established based  on several  chronic studies.    The
Theoretical  Maximum  Residue  Contribution  (TMRC)  for the  U.S.  population  is
0.000065 mgAg/day/  corresponding  to  0.006% of the RfD.  A  proposed increase in
the peach tolerance  from 0.1 to  0.35 ppm would result  in a TMRC of  0.000118

-------
mg/kg/day.   The  largest subgroups,  nursing and non-nursing  infants,  represent
0.061% and 0.076% respectively of the current RfD.

      3.  The  potential  for  development  of  oxytetracycline  resistance due  to
increased background  levels from pesticidal uses to applicators and field workers
appears minimal.

      4.  The Agency  is  unable to  assess the  potential for  oxytetracycline  to
contaminate  ground water  because the  environmental  fate of  oxytetracycline  is
uncharacterized.

      5. The Agency  is unable  to assess the ecological effects of oxytetracycline
on terrestrial or aquatic wildlife, because no data are available.

      Toxicology Characteristics

      Qxytetracycline  has been used extensively for over 37 years in animals
and  in man.   It  is one of a  group of  broad spectrum  antibiotics  known  as
tetracyclines which were developed for control of bacterial diseases in man and
animals. As a result  of its human drug use, there is an extensive body of
toxicological data  available  on oxytetracycline.  Thus, all toxicological data
requirements have been waived.

      Chronic toxicity

      Due to various deficiencies, the available studies do not fulfill current
requirements.  Additional data  are  not required,  based upon availability of both
animal and human data from oxytetracycline's drug uses.

      Two 2-year  chronic toxicity studies  in rats are available.   In one study,
Osborne-Mendel  rats  were  fed diets containing  0,  100,   1000 and 3000  ppm,
oxytetracycline hydrochloride in. the diet for 24 months.  The NOEL was determined
to be 3000 ppm, approximately 150 mg/kg/body weight/day, highest dose tested.

      In a second study,  Sprague Dawley rats were fed diets containing 0,100, and
1000  ppm oxytetracycline hydrochloride in  the  diet for 24 months. The  NOEL for
oxytetracycline hydrochloride was 1000 ppm, 50 mg/kg/day, highest dose tested.

     Two chronic  toxicity studies  in dogs are available.   In  the first study,
dogs  were  fed diets  containing 0,  100,  3000,  and 10000 ppm  of oxytetracycline
hydrochloride  in  the  diet  for 24 months.   A  yellow discoloration  of  the long
bones and brownish  discoloration of the thyroid was observed in all dosed animals
at  necropsy.   The  NOEL  was  determined  to  be  10000 ppm,  approximately  250
mg/kg/day, highest  dose tested.

     In a  second study,  mongrel dogs were fed  diets  containing  0, 5000,  and
10000 of oxytetracycline hydrochloride in the diet for  12 months.  The  NOEL was
determined to be 10000 ppm, approximately 250 mg/kg/day, highest dose tested.

-------
     Oncogenicitv

     NCI/NTP Qxytetracycline Qncogenicity Study in the F344N/Rat

     In this study, oxytetracycline hydrochloride (purity 98.8%) was administered
to  groups of F344/N rats fed 0,  25000,  and 50000 ppm in the diet for 103 weeks.
Fatty  metamorphosis of the liver was  increased in rats in the  low dose group.
Die National Toxicology  Program concluded that ".  .   .  .  there  was equivocal
evidence1 of carcinogenicity  for male F344/TJ  rats as indicated  by increased
incidences  of  pheochromocytomas of  the  adrenal  gland.    There  was equivocal
evidence  of carcinogenicity  for female F344/N rats  as indicated by increased
incidences of adenomas of the pituitary  gland in the high dose group."

     NCI/NTP Qxytetracycline Qncogenicity Study in the B6C3F1 lYbuse

     In this study, oxytetracycline hydrochloride (purity 98.8%) was administered
to  groups of B6C3F1 mice fed 0,  6300,  and 12500 ppm in the  diet for 103 weeks.
The National Toxicology  Program concluded that "... there  was no  evidence of
carcinogenicity for male or female B6C3F1 mice fed diets containing 6300 or 12500
ppm of oxytetracycline hydrochloride for. 2 years."

     Teratogenic itv

     Female  Charles  River CD  rats  were  dosed during days  6  through 15  of
gestation with  1200,  1350,  or  1500  rog/kg  of oxytetracycline  hydrochloride.
There were dose-related decreases in maternal  survival and body weight gain, and
increases in the incidence  of  respiratory difficulties  and rough  coat.    In
addition, there were significant  dose-related decreases  in the percent of treated
dams found pregnant. There was also a dose-related decrease in fetal body weight.
The high incidence of  maternal  deaths  and the fetotoxicity noted in  all  dose
levels tested did not allow  for an establishment of  a NOEL.  The T.FT. was  1200
mg/kg/day (lowest dose tested).

     The  significant  findings discussed in this study can be  attributed to the
excessive dose  levels used, and the overly stressing of the treated dams.

     Female  CD-I  mice were dosed during day 6  through  15 of gestation  with 0,
1325,  1670,  and  2100 mg/kg oxytetracycline hydrochloride.   No  adverse effects
were  demonstrated,  due  probably to  the  low  dose  levels  used.   The NOEL  for
maternal  and developmental toxicity in  this study was  2100  mg/kg (highest  dose
tested).
     1 The  NCI/TSTTP  uses five  levels  of interpretative  evaluations  in  animal
carcinogenesis  studies;  in decreasing  order  of  strength  (not  potency  or
mechanism)  of   the  experimental  evidence,  these  are:   (i)   clear  evidence
ofcarcinogenicity  (ii) some evidence of carcinogenicity, (iii) equivocal evidence
of carcinogenicity,  (iv) no evidence of carcinogenicity, and (v) inadequate study
of carcinogenicity.

-------
     Antibiotic Microbial Resistance

     Mature beagles were  fed a diet containing 0,  2, or 10 ppm, approximately of
oxytetracycline  for 44 days.   The  10 ppm  (0.25  mg/kg/day)  diet resulted  in a
shift  from  a  predominantly  drug-susceptible population of  enteric  lactose-
fermenting organisms  to a multiple antibiotic-resistant population.  A shift to
drug-resistance  did  not  occur  in  the  group fed 2  ppm  approximately  0.05
mg/kg/day.  The NOEL was 0.05 mg/kg/day.

4.   TOLESffiKCE ASSESSMENT

     Tolerances have been established for  residues of oxytetracycline in two raw
agricultural commodities  (40 CFR 180.337).  Use of oxytetracycline  as  a drug in
food animals is  regulated by the FUV according to 21 CFR 520, 522, 524, and 558.
The Fm  has  established tolerances for oxytetracycline  in or on meat,  fat,  meat
byproducts, and  in uncooked edible tissues of salmonoid fish and catfish (21 CFR
556.500).

     No  data   are  available  to  evaluate  the  nature  of   the   residue  of
oxytetracycline in plants.   The Agency has assessed the need for data reflecting
the metabolism   of oxytetracycline  in plants and has concluded that these  data
are not required because of the drug uses of oxytetracycline.

     No  data  are available    to  evaluate  the  nature  of   the  residue  of
oxytetracycline  in animals.   However, data on  the metabolism of oxytetracycline
in food  animals are not  required: residues of oxytetracycline  in meat and  milk
are unlikely since there are  no registered uses of animal feed items at the
present time.

     The  available  microbiological  assay  method  for  the  determination  of
oxytetracycline residues  in or on peaches, nectarines and pears is adequate for
data collection and for tolerance  enforcement.  The Agency will  not require any
additional analytical  methods  at this  time.   The method is  similar to  Final
Action Microbiological Methods  I  and II in the AOAC Official Methods of Analysis
(1984;42.293-42.298).

5.   summary of Regulatory Positions

       Oxytetracycline is not a candidate for Special Review at  this time.

       Oxytetracycline does not meet the criteria for restricted use
       classification.

       The Agency will continue to grant new uses for oxytetracycline.

       The Agency will propose that the tolerance level for peaches be increased
       from 0.1 ppm to 0.35 ppm.

       The Agency will not propose the establishment of crop group tolerances
       for pome fruits or stone fruits.

-------
        Current tolerances are sufficient to cover the  actual residues resulting
        from tree injections  (pears only) and foliar applications.

        The Agency is deferring its decision.concerning the potential of
        oxytetracycline to contaminate groundwater until information on its
        environmental fate has been sutmitted and evaluated.

        The Agency believes that the potential for development of resistant
        microorganisms in applicators and/or field workers as a result of
        exposure are negligible.
       Potential  for development of oxytetracycline resistant microorganisms
       as a result of dietary exposure is minimal.
6.  Summary of Mferjor Data Gaps

Environmental fate/Exposure:^

Hydrolysis
Photodegradation in water and in soil
Metabolism  Studies (lab)
     -Aerobic Soil
     -Anaerobic Soil
     -Anaerobic Aquatic
     -Aerobic Aquatic
Leaching and Adsorption/Desorption
Dissipation Studies (field)
     -Soil
     -Aquatic (Sediment)
Accumulation in Fish
Timeframe for
 Submission
9
9
Months
Months
27   Months
27   Months
27   Months
27   Months
12   Months

27   Months
27   Months
12   Months
Fish & Wildlife;

Avian Acute Oral LD50
Avian Dietary LC50
Freshwater Fish LC50 (TSM)3
Freshwater Invertebrate  (TStf)

Product Chemistry

All product chemistry studies
9
9
9
9
Months
Months
Months
Months
     Months
         Environmental Fate data requirements only for calcium
         oxytetracycline.
       TGAI: Technical grade of the active ingredient

-------
7.   OCUBVCT PERSON AT
     Larry Schnaubelt
     Product Manager (21)
     Herbicide/Fungicide Branch
     Registration Division (TS-767C)
     Office of Pesticide Programs
     Environmental Protection Agency
     401 M Street, S. W.
     Washington, D. C.  20460

     Office location and telephone number:

     Room 227, Crystal Mall #2
     1921 Jefferson Davis Highway
     Arlington, VA  22202
     (703) 557-1900
DISCXAIMR:    The information in this Pesticide Fact Sheet is a
summary only and is not to be used to satisfy data requirements for
pesticide registration and reregistration.  The complete Registration
Standard for the pesticide may be obtained from the National Technical
Information Service.  Contact the Product Manager listed above for
further information.

-------